Lv63
2890 积分 2024-02-22 加入
Therapeutic T cell engineering
8天前
已完结
Chimeric antigen receptor T cell therapy: 25years in the making
11天前
已完结
Toxicities of chimeric antigen receptor T cells: recognition and management
11天前
已完结
Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models
19天前
已完结
Generation of Monoclonal Antibodies Against a Human T Cell Receptor β Chain Expressed in Transgenic Mice
19天前
已完结
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
20天前
已完结
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
20天前
已完结
DR5 CAR-NK cells demonstrate superior scalability and potent antitumor activity with favorable safety
21天前
已完结
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity
21天前
已完结
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
22天前
已完结
皖公网安备34019202002308
